Thompson Siegel & Walmsley’s Sanofi SNY Stock Holding History

Thompson Siegel & Walmsley’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-206	Closed	-$9K	–	824
2017 Q4	$9K	Hold	206	–	–	﹤0.01%	728
2017 Q3	$10K	Hold	206	–	–	﹤0.01%	709
2017 Q2	$10K	Hold	206	–	–	﹤0.01%	706
2017 Q1	$9K	Buy	+206	New	+$8.74K	﹤0.01%	709
2015 Q2	–	Sell	-4,064	Closed	-$201K	–	719
2015 Q1	$201K	Buy	+4,064	New	+$194K	﹤0.01%	388

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thompson Siegel & Walmsley's SNY Position: Q1 2018 in Review

Thompson Siegel & Walmsley sold out of Sanofi (SNY) in Q1 2018, closing a stake of 206 shares — an estimated $9K sold.

Thompson Siegel & Walmsley first reported a position in SNY in Q1 2015 and held it in 5 quarters. The position peaked at $201K in Q1 2015. 487 funds tracked by Wall St. Rank hold SNY as of Q1 2018.

Thompson Siegel & Walmsley reported no remaining Sanofi position as of Q1 2018 after selling out during the quarter.
Thompson Siegel & Walmsley sold 206 Sanofi shares in Q1 2018, an estimated $9K.
Thompson Siegel & Walmsley first reported a position in Sanofi in Q1 2015 and held it in 5 quarters.
Thompson Siegel & Walmsley's Sanofi position peaked at $201K in Q1 2015.
487 funds tracked by Wall St. Rank held Sanofi as of Q1 2018.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2018, filed 8 May 2018.